Travel Vaccine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

The report on the global travel vaccine market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global travel vaccine market to grow with a CAGR of 9.2% over the forecast period from 2019-2025. The study on travel vaccine market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on travel vaccine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global travel vaccine market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global travel vaccine market over the period of 2017 to 2025. Further, the Growth Matrix given in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings:

1. Drivers

• Enormous rise in number of tourist
• Stringent regulations for health safety by regional government bodies

2. Restraints

• High cost and unskillful resource persons for production of disease specific vaccine

3. Opportunities

• Advancement in technology, awareness programs by government and private organizations

Research Methodology

A. Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated with the publisher
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B. Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global travel vaccine market is segmented on the basis of composition, and type.

The Global Travel Vaccine Market by Composition

• Mono Vaccine
• Combination Vaccines

The Global Travel Vaccine Market by Type

• Attenuated Vaccines
• Inactive Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Conjugate Vaccines
• DNA Vaccines
• Recombinant Vector Vaccines

Company Profiles

The companies covered in the report include

• GlaxoSmithKline plc
• Pfizer Inc.
• F. Hoffman-La Roche Ltd.
• Merck & Co., Inc.
• Abbott Laboratories
• Sanofi S.A
• Dynavax Technologies Corporation
• Shenzhen Kangtay Biological Products Co.
• Baxter International
• Takeda Pharmaceuticals U.S.A., Inc.
• Other companies

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the travel vaccine market.
2. Complete coverage of all the segments in the travel vaccine market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global travel vaccine market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.